Flecainide
Showing 1 - 25 of 81
Atrial Fibrillation, Surgery Trial (Flecainide)
Not yet recruiting
- Atrial Fibrillation
- Surgery
- Flecainide
- (no location specified)
Nov 16, 2023
Patent Foramen Ovale, Atrial Fibrillation, Cryptogenic Stroke Trial in Paris (Flecainide)
Enrolling by invitation
- Patent Foramen Ovale
- +2 more
- Flecainide
-
Paris, IDF, FranceHopital Pitié Salpetrière
Jul 22, 2022
Paroxysmal Atrial Fibrillation (PAF) Trial in Belgium, Netherlands (Flecainide Acetate)
Completed
- Paroxysmal Atrial Fibrillation (PAF)
- Flecainide Acetate
-
Bonheiden, Belgium
- +8 more
Dec 2, 2022
Mitral Valve Prolapse, Ventricular Arrhythmias and Cardiac Arrest Trial in Oslo (Flecainide, Metoprolol)
Recruiting
- Mitral Valve Prolapse
- Ventricular Arrhythmias and Cardiac Arrest
- Flecainide
- Metoprolol
-
Oslo, NorwayOslo University Hospital Rikshospitalet
Jan 6, 2023
Atrial Fibrillation Paroxysmal, Coronary Artery Disease Without Residual Ischemia Trial in Athens (Flecainide Injectable
Not yet recruiting
- Atrial Fibrillation Paroxysmal
- Coronary Artery Disease Without Residual Ischemia
- Flecainide Injectable Solution
- Amiodarone Injectable Solution
-
Athens, Attiki, Greece
- +2 more
Sep 18, 2022
Atrial Fibrillation Trial in Lille (Flecainide controlled release)
Completed
- Atrial Fibrillation
- Flecainide controlled release
-
Lille, FranceHopital Cardiologique, Service de Cardiologique CHR de Lille
Feb 4, 2022
The Use of Flecainide for Treatment of Atrial Fibrillation
Recruiting
- Atrial Fibrillation
- Global peak atrial longitudinal strain and ECG
-
Helsingborg, Skane, SwedenClinical Sciences, Helsingborg Medical Faculty Lund University
Mar 23, 2022
Paroxysmal Atrial Fibrillation Trial in Madrid (Vernakalant, Flecainide)
Recruiting
- Paroxysmal Atrial Fibrillation
- Vernakalant
- Flecainide
-
Madrid, Madrid/Madrid, SpainHospital Clínico Universitario San Carlos
Aug 5, 2022
Atrial Fibrillation, Arrhythmias, Cardiac Trial in Chios (Flecainide Injectable Product)
Completed
- Atrial Fibrillation
- Arrhythmias, Cardiac
- Flecainide Injectable Product
-
Chios, GreeceSkylitseio General Hospital
Aug 4, 2021
Arrhythmogenic Right Ventricular Cardiomyopathy Trial in United States (Flecainide Pill, Placebo)
Recruiting
- Arrhythmogenic Right Ventricular Cardiomyopathy
- Flecainide Pill
- Placebo
-
Denver, Colorado
- +5 more
Sep 9, 2021
Atrial Fibrillation, Atrial Fibrillation New Onset, Atrial Fibrillation, Persistent Trial in Canada (Cryoballoon-based PVI,
Active, not recruiting
- Atrial Fibrillation
- +12 more
- Cryoballoon-based PVI
- Anti-Arrhythmic Drug Therapy
-
Calgary, Alberta, Canada
- +17 more
Aug 22, 2022
Atrial Fibrillation, Persistent Trial in Worldwide (Pulmonary vein isolation, dronedarone - Multaq™ OR flecainide - Tambocor™ OR
Not yet recruiting
- Atrial Fibrillation, Persistent
- Pulmonary vein isolation
- dronedarone - Multaq™ OR flecainide - Tambocor™ OR propafenone - Rytmonorm™ OR sotalol - Sotacor™
-
Pecs, Hungary
- +5 more
Jul 2, 2023
Atrial Fibrillation Trial in Worldwide (Flecainide)
Terminated
- Atrial Fibrillation
- Flecainide
-
Bonheiden, Belgium
- +46 more
Feb 4, 2022
Narcolepsy Trial in Belgium, France (Active comparator: Modafinil + , THN102 300/3, THN102 300/27)
Completed
- Narcolepsy
- Active comparator: Modafinil + placebo
- +2 more
-
Erpent, Belgium
- +7 more
Aug 18, 2020
Fetal Atrial Flutter Without Hydrops, Fetal Supraventricular Tachycardia Without Hydrops, Fetal Supraventricular Tachycardia
Recruiting
- Fetal Atrial Flutter Without Hydrops
- +2 more
- Digoxin (monotherapy)
- +5 more
-
San Francisco, California
- +28 more
Oct 12, 2021
Shortening Duration of Antiarrhythmic Medication for SVT in
Recruiting
- Supraventricular Tachycardia
- Propranolol
- +2 more
-
Jyväskylä, Central Finland, Finland
- +17 more
Sep 28, 2021
Atrial Fibrillation Trial in Canada (Cryoballoon-based PVI, Anti-Arrhythmic Drug Therapy)
Active, not recruiting
- Atrial Fibrillation
- Cryoballoon-based PVI
- Anti-Arrhythmic Drug Therapy
-
Calgary, Alberta, Canada
- +17 more
Jun 4, 2021
Atrial Fibrillation Trial in Netherlands (Pharmacological cardioversion - Flecainide, Electrical cardioversion, Metoprolol)
Completed
- Atrial Fibrillation
- Pharmacological cardioversion - Flecainide
- +5 more
-
Amsterdam, Netherlands
- +14 more
Jan 17, 2020
Mild Cognitive Impairment, Persistent Atrial Fibrillation Trial in France (Atrial fibrillation ablation + antiarrhythmic drugs,
Not yet recruiting
- Mild Cognitive Impairment
- Persistent Atrial Fibrillation
- Atrial fibrillation ablation + antiarrhythmic drugs
- Antiarrhythmic drug
-
Brest, France
- +5 more
Mar 16, 2023
Atrial Fibrillation, Recurrence Trial (Ranolazine plus Metoprolol Combination, FlecainidE pluS Metoprolol Combination)
Withdrawn
- Atrial Fibrillation
- Recurrence
- Ranolazine plus Metoprolol Combination
- FlecainidE pluS Metoprolol Combination
- (no location specified)
May 10, 2019
Flecainide Infusion Test in Brugada Syndrome
Completed
- Brugada Syndrome
- Arrhythmogenic Right Ventricular Cardiomyopathy
- flecainide iv
-
New York, New YorkNew york University, School of Medicine
Apr 16, 2019
Atrial Fibrillation Trial in Worldwide (Pulmonary vein isolation using CLOSE protocol, Antiarrhythmic drug therapy (ADT))
Completed
- Atrial Fibrillation
- Pulmonary vein isolation using CLOSE protocol
- Antiarrhythmic drug therapy (ADT)
-
Graz, Austria
- +8 more
Jul 8, 2022
Long QT Syndrome Trial in Rochester (Placebo, Ranolazine)
Completed
- Long QT Syndrome
- Placebo
- Ranolazine
-
Rochester, New YorkUniversity of Rochester
Mar 15, 2022
Ventricular Premature Complexes, Blood Pressure Trial in Madison (PVC Suppression using Flecainide, No PVC Suppression using
Terminated
- Ventricular Premature Complexes
- Blood Pressure
- PVC Suppression using Flecainide
- No PVC Suppression using Placebo
-
Madison, WisconsinUniversity of Wisconsin
Jan 29, 2019
Brugada Syndrome Trial (ablation)
Not yet recruiting
- Brugada Syndrome
- ablation
- (no location specified)
Dec 14, 2022